SG99494G - Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical containing it - Google Patents

Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical containing it

Info

Publication number
SG99494G
SG99494G SG99494A SG99494A SG99494G SG 99494 G SG99494 G SG 99494G SG 99494 A SG99494 A SG 99494A SG 99494 A SG99494 A SG 99494A SG 99494 G SG99494 G SG 99494G
Authority
SG
Singapore
Prior art keywords
ciclosporin
orthorhombic
production
crystal form
pharmaceutical containing
Prior art date
Application number
SG99494A
Other languages
English (en)
Inventor
Danielle Giron
Martin List
Friedrich Richter
Yasuyuki Uike
Hans Peter Weber
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Priority to SG99494A priority Critical patent/SG99494G/en
Publication of SG99494G publication Critical patent/SG99494G/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
SG99494A 1987-12-21 1994-07-21 Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical containing it SG99494G (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG99494A SG99494G (en) 1987-12-21 1994-07-21 Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical containing it

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US17261388A 1988-03-24 1988-03-24
US21254888A 1988-06-28 1988-06-28
SG99494A SG99494G (en) 1987-12-21 1994-07-21 Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical containing it

Publications (1)

Publication Number Publication Date
SG99494G true SG99494G (en) 1994-10-28

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
SG99494A SG99494G (en) 1987-12-21 1994-07-21 Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical containing it

Country Status (27)

Country Link
JP (1) JPH0791316B2 (xx)
KR (1) KR100188305B1 (xx)
AT (1) AT403163B (xx)
AU (1) AU626274B2 (xx)
BE (1) BE1002665A4 (xx)
CA (1) CA1341396C (xx)
CH (1) CH677926A5 (xx)
CY (1) CY1799A (xx)
DE (1) DE3843054C2 (xx)
DK (1) DK175220B1 (xx)
ES (1) ES2012580A6 (xx)
FI (1) FI89065C (xx)
FR (1) FR2624863B1 (xx)
GB (1) GB2211848B (xx)
GR (1) GR1002486B (xx)
HK (1) HK102894A (xx)
HU (1) HU203564B (xx)
IE (1) IE62006B1 (xx)
IL (1) IL88719A0 (xx)
IT (1) IT1235356B (xx)
LU (1) LU87409A1 (xx)
MY (1) MY103943A (xx)
NL (1) NL195096C (xx)
NO (1) NO177228C (xx)
NZ (1) NZ227384A (xx)
SE (1) SE503174C2 (xx)
SG (1) SG99494G (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
WO1993023010A1 (en) * 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
EP0789580B1 (de) 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US6262054B1 (en) 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
ES2229473T3 (es) 1997-01-30 2005-04-16 Novartis Ag Composiciones farmaceuticas sin aceite que contienen ciclosporina a.
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
EP1706095B1 (en) 2004-01-20 2008-12-24 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
CN1763084B (zh) * 2005-10-11 2010-04-21 山东新时代药业有限公司 高纯度环孢菌素a的制备方法
JP6163482B2 (ja) 2011-05-27 2017-07-12 アラーガン、インコーポレイテッドAllergan,Incorporated シクロスポリンaの結晶形態、その調製方法、およびその使用のための方法
JP6204921B2 (ja) * 2011-11-15 2017-09-27 アラーガン、インコーポレイテッドAllergan,Incorporated シクロスポリンaの形態2およびその作製方法
AU2012339701B8 (en) * 2011-11-15 2017-11-16 Allergan, Inc. Autoclavable suspensions of cyclosporin A Form 2
EP3701939A1 (en) * 2011-11-15 2020-09-02 Allergan, Inc. Suspensions of cyclosporin a form 2
CA2856044C (en) 2011-11-15 2016-11-29 Allergan, Inc. Sustained action formulation of cyclosporin form 2
WO2024085235A1 (ja) * 2022-10-20 2024-04-25 中外製薬株式会社 環状ペプチドの結晶の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (xx) * 1975-11-04 1979-12-28 Sandoz Ag
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Also Published As

Publication number Publication date
AT403163B (de) 1997-11-25
GB2211848B (en) 1991-11-06
HUT49893A (en) 1989-11-28
FR2624863A1 (fr) 1989-06-23
AU626274B2 (en) 1992-07-30
HU203564B (en) 1991-08-28
IT1235356B (it) 1992-06-30
ES2012580A6 (es) 1990-04-01
GB2211848A (en) 1989-07-12
LU87409A1 (fr) 1989-07-07
NO177228C (no) 1995-08-09
ATA309588A (de) 1997-04-15
HK102894A (en) 1994-09-30
IL88719A0 (en) 1989-07-31
FI885869A (fi) 1989-06-22
KR890009975A (ko) 1989-08-05
DE3843054A1 (de) 1989-07-27
BE1002665A4 (fr) 1991-04-30
SE503174C2 (sv) 1996-04-15
JPH0791316B2 (ja) 1995-10-04
CY1799A (en) 1995-02-17
DE3843054C2 (de) 2003-08-21
SE8804570D0 (sv) 1988-12-19
FI885869A0 (fi) 1988-12-19
SE8804570L (sv) 1989-06-22
KR100188305B1 (ko) 1999-06-01
FI89065C (fi) 1993-09-30
DK705488A (da) 1989-06-22
DK175220B1 (da) 2004-07-12
NL195096C (nl) 2004-02-09
FR2624863B1 (fr) 1991-04-26
IE62006B1 (en) 1994-12-14
NO885625D0 (no) 1988-12-19
IT8848690A0 (it) 1988-12-20
JPH01211598A (ja) 1989-08-24
NZ227384A (en) 1991-09-25
MY103943A (en) 1993-10-30
AU2705588A (en) 1989-06-22
DK705488D0 (da) 1988-12-19
NO885625L (no) 1989-06-22
GR880100850A (el) 1994-03-31
NO177228B (no) 1995-05-02
FI89065B (fi) 1993-04-30
IE883779L (en) 1989-06-21
NL8803125A (nl) 1989-07-17
CA1341396C (en) 2002-11-05
GB8829556D0 (en) 1989-02-08
GR1002486B (el) 1996-12-09
CH677926A5 (xx) 1991-07-15

Similar Documents

Publication Publication Date Title
SG99494G (en) Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical containing it
HUT45954A (en) Process for producing tetrahydronaphtalene- and indanederivatives and pharmaceutical compositions containing them
HUT51272A (en) Process for producing thiadiazin derivatives and pharmaceutical composirions containing them
EP0359831A4 (en) Biosensor and process for its production
EP0446961A3 (en) Stabilized pharmaceutical composition and its production
HUT48900A (en) Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them
HUT53644A (en) Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them
HU903281D0 (en) Process for producing 2-hydroxy-n-propyl-amines and containing them pharmaceutical preparatives
AU596690B2 (en) Sweets and process for their manufacture
HU894124D0 (en) Process for producing peptides and pharmaceutical preparatives containing these peptides
HUT47278A (en) Process for producing pyrrolo-benzimidazols and pharmaceutical compositions containing them
HUT51143A (en) Process for production of homogenisate of piroxicame and capsule or pill made from it
HUT50121A (en) Process for producing piperidinyl-derivatives and pharmaceutical compositions containing them
HUT47846A (en) Process for producing antimalarian pharmaceutical
IL86094A (en) Crystalline human proinsulin, process for its production and pharmaceutical compositions containing it
EP0245034A3 (en) Packaging structure and process for production thereof
EP0247740A3 (en) Novel isocarbacyclins and processes for production thereof
ZA872500B (en) Antibiotic a42125 and process for its production
HU896004D0 (en) Pharmaceutical peparations containing paf-antagonists, and their production process
HU202557B (en) Process for producing sialinic acid-octapeptide and pharmaceutical compositions containing them
HU908470D0 (en) Process for the production of pyrimidine-5-yl-alcane carbonic acid-esthers
HUT47292A (en) Process for producing thieno-thiopiranes and pharmaceutical compositions containing them
HU893527D0 (en) Process for the production of proburzine and pharmaceutical preparations containing thereof
EP0296479A3 (en) Fluorobenzoates and process for their production
ZA889540B (en) New cyclosporin crystal form,processes for its production,pharmaceutical compositions containing it and its use